No connection

Search Results

BKD vs PRVA

BKD
Brookdale Senior Living Inc.
BEARISH
Price
$12.95
Market Cap
$3.08B
Sector
Healthcare
AI Confidence
85%
PRVA
Privia Health Group, Inc.
NEUTRAL
Price
$24.02
Market Cap
$3.02B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
BKD
--
PRVA
126.42
Forward P/E
BKD
-23.33
PRVA
20.08
P/B Ratio
BKD
-462.5
PRVA
4.03
P/S Ratio
BKD
1.0
PRVA
1.42
EV/EBITDA
BKD
18.07
PRVA
57.87

Profitability

Gross Margin
BKD
27.57%
PRVA
9.87%
Operating Margin
BKD
2.36%
PRVA
2.08%
Profit Margin
BKD
-9.95%
PRVA
1.08%
ROE
BKD
-212.27%
PRVA
4.03%
ROA
BKD
0.92%
PRVA
1.71%

Growth

Revenue Growth
BKD
4.2%
PRVA
17.4%
Earnings Growth
BKD
--
PRVA
132.8%

Financial Health

Debt/Equity
BKD
--
PRVA
0.01
Current Ratio
BKD
0.84
PRVA
1.6
Quick Ratio
BKD
0.5
PRVA
1.55

Dividends

Dividend Yield
BKD
--
PRVA
--
Payout Ratio
BKD
0.0%
PRVA
0.0%

AI Verdict

BKD BEARISH

The Advanced Deterministic Scorecard reveals a deeply concerning financial profile for Brookdale Senior Living (BKD), with a Piotroski F-Score of just 2/9 indicating severe weakness in fundamental health. Despite strong recent price performance (+163.2% over 1Y), the company is unprofitable (ROE: -212.27%, Profit Margin: -9.95%), carries significant liquidity risk (Current Ratio: 0.84), and has consistently missed earnings estimates—0 out of the last 4 quarters beaten, with an average surprise of -101.87%. Valuation metrics are distorted (Price/Book: -462.50, Forward P/E: -23.33) due to negative equity and earnings, while the lack of an Altman Z-Score suggests potential distress risk. Analysts rate it a 'strong_buy' but with only 4 analysts and no meaningful insider activity, the bullish sentiment lacks conviction.

Strengths
Revenue growth of 4.20% YoY shows modest top-line resilience in a challenging senior care environment
Gross margin of 27.57% indicates some operational efficiency at the core service level
Price/Sales ratio of 1.00 is reasonable relative to unprofitable peers in the healthcare sector
Risks
Piotroski F-Score of 2/9 signals extreme financial distress and poor earnings quality
Negative book value and ROE of -212.27% indicate eroding shareholder equity and likely balance sheet insolvency
Current Ratio of 0.84 and Quick Ratio of 0.50 reveal acute liquidity risk and inability to meet short-term obligations
PRVA NEUTRAL

PRVA presents a stark contrast between fundamental value and growth expectations, anchored by a stable Piotroski F-Score of 4/9. While the company maintains an exceptionally clean balance sheet with near-zero debt, it trades at a massive premium compared to its Graham Number ($5.05) and Intrinsic Value ($5.61). Strong analyst conviction and impressive YoY earnings growth are currently offset by aggressive insider selling from the CEO and CFO and razor-thin profit margins. The stock is essentially a high-growth bet where the market is pricing in future earnings far beyond current deterministic valuations.

Strengths
Exceptionally low Debt/Equity ratio (0.01), indicating minimal financial leverage risk
Strong revenue growth (17.40% YoY) and explosive annual earnings growth (132.80%)
Consistent track record of beating earnings estimates (3 of last 4 quarters)
Risks
Extreme valuation gap: Current price ($24.02) is >4x the Graham Number ($5.05)
Very thin profitability margins (Profit Margin: 1.08%, Gross Margin: 9.87%)
Bearish insider sentiment with significant selling by the CEO and CFO

Compare Another Pair

BKD vs PRVA: Head-to-Head Comparison

This page compares Brookdale Senior Living Inc. (BKD) and Privia Health Group, Inc. (PRVA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile